Top in cardiology: Omega-3 fatty acids and CVD, missed HF diagnoses in primary care
Click Here to Manage Email Alerts
In the VITAL trial, marine omega-3 fatty acids did not prevent stroke, but they did reduce the risk for myocardial infarction compared with an olive oil placebo. A review of the data was the top story in cardiology last week.
Another top story was about new data that showed gender, race and occupation status can affect how an individual receives a heart failure diagnosis. White men who are not retired were more likely to be diagnosed in a primary care setting than women, Black patients or a patient categorized as a “homemaker” or “retired,” who were more often diagnosed in an acute care setting.
Read these and more top stories in cardiology below:
Omega-3 fatty acids may have role in CVD prevention, but vitamin D supplements do not
Trials of omega-3 fatty acids have indicated they may have a role in CVD prevention, but the same cannot be said for vitamin D supplements, according to a speaker at the American Society for Preventive Cardiology Congress on CVD Prevention. Read more.
Chance for early HF diagnosis in a primary care setting missed for many women, Black patients
Women and Black individuals are more likely to be diagnosed with heart failure in an acute care setting than a primary care setting compared men and white patients, respectively, according to data published in Circulation: Heart Failure. Read more.
Marijuana use may not elevate stroke risk among young adults
Marijuana use was not associated with risk for ischemic stroke among young adults compared with never users, according to research published in Stroke. Read more.
Patient autonomy to place do-not-resuscitate order low in COVID-19 hospitalization
Among high-risk patients, discussion of do-not-resuscitate orders should take place prior to hospitalization, as only 10% of patients possessed the autonomy to do so after admission for severe COVID-19, a speaker at the American Society for Preventive Cardiology Congress on CVD Prevention reported. Read more.
MINOCA not benign, should be treated as a syndrome
Data show that patients with myocardial infarction or ischemia without obstructive coronary artery disease are at elevated risk for poor cardiovascular outcomes and doctors need to pinpoint the cause of ischemia. Read more.